As of today (2024-04-26), Surface Oncology's share price is $1.07.
Surface Oncology's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $-1.39. Hence, Surface Oncology's Price-to-Free-Cash-Flow Ratio for today is N/A.
The historical rank and industry rank for Surface Oncology's Price-to-Free-Cash-Flow or its related term are showing as below:
During the past 7 years, Surface Oncology's highest Price-to-Free-Cash-Flow Ratio was 83.19. The lowest was 13.14. And the median was 22.58.
SURF's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 30.76 * Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 21.40% per year.
During the past 7 years, Surface Oncology's highest 3-Year average Free Cash Flow per Share Growth Rate was 21.40% per year. The lowest was -22.80% per year. And the median was -0.70% per year.
Surface Oncology Price-to-Free-Cash-Flow Historical Data
The historical data trend for Surface Oncology's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Surface Oncology's Price-to-Free-Cash-Flow
For the Biotechnology subindustry, Surface Oncology's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surface Oncology's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Surface Oncology's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Surface Oncology's Price-to-Free-Cash-Flow falls into.
Surface Oncology's Share Price of today is $1.07. Surface Oncology's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.39.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Surface Oncology Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Surface Oncology's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Surface Oncology (Surface Oncology) Business Description
Surface Oncology Inc is a clinical-stage immuno-oncology company. It is developing new therapies that modify the spaces in and around tumors in the tumor microenvironment to create conditions that support and sustain anti-tumor immune responses. The company's pipeline products are SRF231, SRF373, SRF617, and SRF388. Geographically, the activities are carried out throughout the region of the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SURF has been successfully added to your 